Shenzhen Transsion Holdings Co., Ltd. (688036.SH): The maximum H-share issue price shall not exceed HK$38.8 per share.
Shenzhen Transsion Holdings Co., Ltd. (688036.SH) announced that the Company's initial number of H shares under the Global Offering is 86,648,300 shares (subject to the exercise of the Over-allotment Option), of which 8,664,900 shares are initially allocated for the Hong Kong Public Offering (subject to reallocation), representing approximately 10% of the total number of shares under the Global Offering; and 77,983,400 shares are allocated for the International Offering (subject to reallocation and the exercise of the Over-allotment Option), representing approximately 90% of the total number of shares under the Global Offering.
Shenzhen Transsion Holdings Co., Ltd. (688036.SH) announced that the initial number of H shares in this global offering is 86,648,300 shares (subject to the exercise of the over-allotment option), of which the initial Hong Kong public offering is 8,664,900 shares (subject to reallocation), accounting for approximately 10% of the total global offering; the international offering is 77,983,400 shares (subject to reallocation and the exercise of the over-allotment option), accounting for approximately 90% of the total global offering.
The maximum issue price for this H-share offering shall not exceed HK$38.80 per share. The Hong Kong public offering of the Company's H shares commenced on October 7, 2026, and is expected to close on October 12, 2026, with the offer price expected to be announced on or before October 14, 2026. The H shares issued in this offering are expected to be listed and commence trading on the Hong Kong Stock Exchange on October 15, 2026.
Related Articles
REMEGEN (09995) repurchased a cumulative 60,000 shares as of the end of September.
Cofoe Medical Technology (01187) had cumulatively repurchased 2,516,900 A shares as of the end of September.
XIAO NOODLES (02408) repurchased 98,500 shares for HK$405,700 on October 8.
REMEGEN (09995) repurchased a cumulative 60,000 shares as of the end of September.
Cofoe Medical Technology (01187) had cumulatively repurchased 2,516,900 A shares as of the end of September.
XIAO NOODLES (02408) repurchased 98,500 shares for HK$405,700 on October 8.
